BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

776 related articles for article (PubMed ID: 29619879)

  • 1. Cisplatin-induced oxidative stress stimulates renal Fas ligand shedding.
    Soni H; Kaminski D; Gangaraju R; Adebiyi A
    Ren Fail; 2018 Nov; 40(1):314-322. PubMed ID: 29619879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tempol, a membrane-permeable radical scavenger, reduces oxidant stress-mediated renal dysfunction and injury in the rat.
    Chatterjee PK; Cuzzocrea S; Brown PA; Zacharowski K; Stewart KN; Mota-Filipe H; Thiemermann C
    Kidney Int; 2000 Aug; 58(2):658-73. PubMed ID: 10916089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cilastatin attenuates vancomycin-induced nephrotoxicity via P-glycoprotein.
    Im DS; Shin HJ; Yang KJ; Jung SY; Song HY; Hwang HS; Gil HW
    Toxicol Lett; 2017 Aug; 277():9-17. PubMed ID: 28549670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early septic insult in neonatal pigs increases serum and urinary soluble Fas ligand and decreases kidney function without inducing significant renal apoptosis.
    Soni H; Adebiyi A
    Ren Fail; 2017 Nov; 39(1):83-91. PubMed ID: 27767365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal tubular Fas ligand mediates fratricide in cisplatin-induced acute kidney failure.
    Linkermann A; Himmerkus N; Rölver L; Keyser KA; Steen P; Bräsen JH; Bleich M; Kunzendorf U; Krautwald S
    Kidney Int; 2011 Jan; 79(2):169-78. PubMed ID: 20811331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Melatonin, a pineal secretory product with antioxidant properties, protects against cisplatin-induced nephrotoxicity in rats.
    Hara M; Yoshida M; Nishijima H; Yokosuka M; Iigo M; Ohtani-Kaneko R; Shimada A; Hasegawa T; Akama Y; Hirata K
    J Pineal Res; 2001 Apr; 30(3):129-38. PubMed ID: 11316323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carnosic acid attenuates renal injury in an experimental model of rat cisplatin-induced nephrotoxicity.
    Sahu BD; Rentam KK; Putcha UK; Kuncha M; Vegi GM; Sistla R
    Food Chem Toxicol; 2011 Dec; 49(12):3090-7. PubMed ID: 21930180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NADPH oxidase 4 promotes cisplatin-induced acute kidney injury via ROS-mediated programmed cell death and inflammation.
    Meng XM; Ren GL; Gao L; Yang Q; Li HD; Wu WF; Huang C; Zhang L; Lv XW; Li J
    Lab Invest; 2018 Jan; 98(1):63-78. PubMed ID: 29106395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dipeptidyl peptidase-4 inhibitor teneligliptin accelerates recovery from cisplatin-induced acute kidney injury by attenuating inflammation and promoting tubular regeneration.
    Iwakura T; Zhao Z; Marschner JA; Devarapu SK; Yasuda H; Anders HJ
    Nephrol Dial Transplant; 2019 Oct; 34(10):1669-1680. PubMed ID: 30624740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intervention of mitochondrial activity attenuates cisplatin-induced acute kidney injury.
    Yang Y; Fu Y; Wang P; Liu S; Sha Y; Zhang Y; Zhang A; Jia Z; Ding G; Huang S
    Int Urol Nephrol; 2019 Jul; 51(7):1207-1218. PubMed ID: 31020626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tempol, a superoxide dismutase mimetic agent, ameliorates cisplatin-induced nephrotoxicity through alleviation of mitochondrial dysfunction in mice.
    Ahmed LA; Shehata NI; Abdelkader NF; Khattab MM
    PLoS One; 2014; 9(10):e108889. PubMed ID: 25271439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective Effect of Panduratin A on Cisplatin-Induced Apoptosis of Human Renal Proximal Tubular Cells and Acute Kidney Injury in Mice.
    Thongnuanjan P; Soodvilai S; Fongsupa S; Chabang N; Vivithanaporn P; Tuchinda P; Soodvilai S
    Biol Pharm Bull; 2021; 44(6):830-837. PubMed ID: 34078815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hesperidin attenuates cisplatin-induced acute renal injury by decreasing oxidative stress, inflammation and DNA damage.
    Sahu BD; Kuncha M; Sindhura GJ; Sistla R
    Phytomedicine; 2013 Mar; 20(5):453-60. PubMed ID: 23353054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of HDAC6 protects against rhabdomyolysis-induced acute kidney injury.
    Shi Y; Xu L; Tang J; Fang L; Ma S; Ma X; Nie J; Pi X; Qiu A; Zhuang S; Liu N
    Am J Physiol Renal Physiol; 2017 Mar; 312(3):F502-F515. PubMed ID: 28052874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of metformin against cisplatin induced acute renal injury in rats: a biochemical and histoarchitectural evaluation.
    Sahu BD; Kuncha M; Putcha UK; Sistla R
    Exp Toxicol Pathol; 2013 Sep; 65(6):933-40. PubMed ID: 23395153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydroxyl radical scavenger ameliorates cisplatin-induced nephrotoxicity by preventing oxidative stress, redox state unbalance, impairment of energetic metabolism and apoptosis in rat kidney mitochondria.
    Santos NA; Bezerra CS; Martins NM; Curti C; Bianchi ML; Santos AC
    Cancer Chemother Pharmacol; 2008 Jan; 61(1):145-55. PubMed ID: 17396264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Curcumin counteracts cisplatin-induced nephrotoxicity by preventing renal tubular cell apoptosis.
    Topcu-Tarladacalisir Y; Sapmaz-Metin M; Karaca T
    Ren Fail; 2016 Nov; 38(10):1741-1748. PubMed ID: 27758164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential roles of hydrogen peroxide and hydroxyl radical in cisplatin-induced cell death in renal proximal tubular epithelial cells.
    Baek SM; Kwon CH; Kim JH; Woo JS; Jung JS; Kim YK
    J Lab Clin Med; 2003 Sep; 142(3):178-86. PubMed ID: 14532906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genipin attenuates cisplatin-induced nephrotoxicity by counteracting oxidative stress, inflammation, and apoptosis.
    Mahgoub E; Kumaraswamy SM; Kader KH; Venkataraman B; Ojha S; Adeghate E; Rajesh M
    Biomed Pharmacother; 2017 Sep; 93():1083-1097. PubMed ID: 28738532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cilastatin attenuates cisplatin-induced proximal tubular cell damage.
    Camano S; Lazaro A; Moreno-Gordaliza E; Torres AM; de Lucas C; Humanes B; Lazaro JA; Milagros Gomez-Gomez M; Bosca L; Tejedor A
    J Pharmacol Exp Ther; 2010 Aug; 334(2):419-29. PubMed ID: 20435919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.